953 related articles for article (PubMed ID: 31883489)
21. Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
Li YH; Zhang B; Yang HK; Li Q; Diao PC; You WW; Zhao PL
Eur J Med Chem; 2017 Jan; 125():1098-1106. PubMed ID: 27810596
[TBL] [Abstract][Full Text] [Related]
22. Hybrids of 4-hydroxy derivatives of goniothalamin and piplartine bearing a diester or a 1,2,3-triazole linker as antiproliferative agents.
Grigolo TA; Braga CB; Ornelas C; Russowsky D; Ferreira-Silva GA; Ionta M; Pilli RA
Bioorg Chem; 2021 Nov; 116():105292. PubMed ID: 34509797
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.
Farooq S; Hussain A; Qurishi MA; Hamid A; Koul S
Anticancer Agents Med Chem; 2018; 18(11):1531-1539. PubMed ID: 29298653
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of novel 1,2,3-triazole substituted-N-alkyl/aryl nitrone derivatives, their anti-inflammatory and anticancer activity.
Sambasiva Rao P; Kurumurthy C; Veeraswamy B; Santhosh Kumar G; Poornachandra Y; Ganesh Kumar C; Vasamsetti SB; Kotamraju S; Narsaiah B
Eur J Med Chem; 2014 Jun; 80():184-91. PubMed ID: 24780595
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents.
Srinivasa Reddy T; Kulhari H; Ganga Reddy V; Subba Rao AV; Bansal V; Kamal A; Shukla R
Org Biomol Chem; 2015 Oct; 13(40):10136-49. PubMed ID: 26346902
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
Nikookar H; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Ranjbar PR; Mahdavi M; Larijani B
Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
31. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
32. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.
Hou W; Luo Z; Zhang G; Cao D; Li D; Ruan H; Ruan BH; Su L; Xu H
Eur J Med Chem; 2017 Sep; 138():1042-1052. PubMed ID: 28759877
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold.
Li BL; Li B; Zhang RL; Zhao JJ; Wang XF; Liu YM; Shi YP; Liu JB; Chen BQ
Bioorg Med Chem Lett; 2016 Feb; 26(4):1279-81. PubMed ID: 26786698
[TBL] [Abstract][Full Text] [Related]
34. Novel menadione hybrids: Synthesis, anticancer activity, and cell-based studies.
Prasad CV; Nayak VL; Ramakrishna S; Mallavadhani UV
Chem Biol Drug Des; 2018 Jan; 91(1):220-233. PubMed ID: 28734085
[TBL] [Abstract][Full Text] [Related]
35. Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles.
Yadav P; Lal K; Kumar A; Guru SK; Jaglan S; Bhushan S
Eur J Med Chem; 2017 Jan; 126():944-953. PubMed ID: 28011424
[TBL] [Abstract][Full Text] [Related]
36. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
[TBL] [Abstract][Full Text] [Related]
37. Design and Antiproliferative Evaluation of Novel Sulfanilamide Derivatives as Potential Tubulin Polymerization Inhibitors.
Fu DJ; Liu JF; Zhao RH; Li JH; Zhang SY; Zhang YB
Molecules; 2017 Sep; 22(9):. PubMed ID: 28872607
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
40. Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents.
Huang X; Shen QK; Zhang HJ; Li JL; Tian YS; Quan ZS
Molecules; 2018 Sep; 23(9):. PubMed ID: 30177642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
